Innoviva (INVA) Change in Receivables (2010 - 2026)
Innoviva (INVA) posted Change in Receivables of -$961000.0 for Q1 2026, down 109.83% on a QoQ basis from $9.8 million in Q3 2025, and up 74.16% year-over-year from -$551792.3 in Q1 2025.
Innoviva (INVA) Change in Receivables (2010 - 2026) Analysis & Trends
Innoviva's Change in Receivables history runs 10 years deep, the most recent figure standing at -$961000.0 for Q1 2026.
- Quarterly Change in Receivables rose 74.16% year-over-year to -$961000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (down 62.16% YoY) and the FY2025 annual result came in at $14.6 million, up 145.44% from the prior year.
- Change in Receivables was -$961000.0 for Q1 2026 at Innoviva, down from $9.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $16.1 million in Q3 2024 and bottomed at -$3.7 million in Q1 2025.
- A 5-year average of $4.2 million and a median of $1.4 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 5980.47% — and 2025, when it plunged 1080.63%.
- Innoviva's Change in Receivables stood at $867000.0 in 2022, then soared by 55.82% to $1.4 million in 2023, then jumped by 1091.12% to $16.1 million in 2024, then tumbled by 39.26% to $9.8 million in 2025, then slumped by 109.83% to -$961000.0 in 2026.
- Business Quant data shows INVA's Change in Receivables at -$961000.0 in Q1 2026, $9.8 million in Q3 2025, and $4.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | -961,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -961,000.00 |
| Mar 31, 2026 | -961,000.00 |
| Sep 30, 2025 | 9.78 Mn |
| Sep 30, 2025 | 9.78 Mn |
| Jun 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 4.25 Mn |
| Mar 31, 2025 | -3.72 Mn |
| Mar 31, 2025 | -3.72 Mn |
| Sep 30, 2024 | 16.09 Mn |
| Sep 30, 2024 | 16.09 Mn |
| Jun 30, 2024 | 12.64 Mn |
| Jun 30, 2024 | 12.64 Mn |
| Mar 31, 2024 | -315,000.00 |
| Mar 31, 2024 | -315,000.00 |
| Sep 30, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -215,000.00 |
| Mar 31, 2023 | 6.09 Mn |
| Mar 31, 2023 | 6.09 Mn |